atenolol has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrahamov, A | 2 |
| Mechoulam, R | 1 |
1 other study available for atenolol and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
An efficient new cannabinoid antiemetic in pediatric oncology.
Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Ch | 1995 |